Início › Miastenia Gravis › Flórida

Ensaios clínicos de Miastenia Gravis em Flórida

22 estudos para Miastenia Gravis estão buscando participantes em locais em Flórida.

Cidades em Flórida

Texto oficial do estudo (Inglês)

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

SFM Clinical Research LLC, Boca Raton

RecrutandoFase 3

Idades de 18 a 74 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07217587

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Cinical Study Site, Boca Raton

RecrutandoFase 3

Idades de 18 a 80 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07647510

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

Visionary Investigators Network, Miami

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07673627

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Visionary Investigators Network, Miami
Visionary Investigators Network, Miami
University of South Florida, Tampa

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07294170

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Visionary Investigators Network, Miami
University of South Florida, Tampa

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07284420

A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

TG Therapeutics Investigational Trial Site, Clearwater

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07673744

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Neurology of Central Florida Research Center, LLC, Altamonte Springs
SFM Clinical Research, LLC, Boca Raton
University of Florida Health Science Center - 300120311, Jacksonville
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06463587

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Neurology Offices, Boca Raton
SFM Clinical Reseach, LLC, Boca Raton
Homestead Associates in Research, Homestead
e mais 3

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07501702

Zilucoplan for Severe gMG Exacerbations

University of South Florida/Tampa General Hospital, Tampa

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07215949

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

SFM Clinical Research, LLC, Boca Raton
Neuromuscular Research Division | University of South Florida, Tampa

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06414954

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Mayo Clinic Florida, Jacksonville

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT06359041

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Aurinia Investigational Site, Altamonte Springs
Aurinia Investigational Site, Boca Raton
Aurinia Investigational Site, Homestead
e mais 2

RecrutandoFase 1/2

Idades de 18 a 85 · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT07596901

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

University of South Florida Morsani Center for Advanced Healthcare, Tampa

RecrutandoFase 2/3

Idades de 2 a 17 · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT05265273

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1006, Clearwater
Site Number - 1037, Ormond Beach
Site Number - 1002, Port Charlotte
e mais 2

RecrutandoFase 3

Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

University of Miami, Miami

RecrutandoFase 2/3

Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT06193889

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

FM Clinical Research, LLC South Florida Neurology Associates, P. A., Boca Raton
Medsol Clinical Research Center Inc, Port Charlotte
University of South Florida, Tampa

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT04951622

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

SFM Clinical Research, Boca Raton
Allied Biomedical Research Institute (ABRI), Miami
Medsol Clinical Research Center, Port Charlotte
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT06456580

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT06626919

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Clinical Trial Site, Clearwater
Clincal Trial Site, Gainesville
Clinical Trial Site, Jacksonville
e mais 1

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 18 de fev. de 2026 · NCT04202341

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

SFM Clinical Research, LLC, Boca Raton
University of Florida College of Medicine Jacksonville, Jacksonville Beach
Medsol Clinical Research Center Inc, Port Charlotte
e mais 1

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 17 de fev. de 2026 · NCT06298565

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Neurology of Central Florida Research Center, LLC, Altamonte Springs
SFM Clinical Research, LLC, Boca Raton
Aqualane Clinical Research, Naples
e mais 2

RecrutandoFase 1/2

Idades de 18 a 74 · Todos os sexos · Atualizado em 11 de fev. de 2026 · NCT07250750

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

University of Florida Health, Jacksonville

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 11 de abr. de 2025 · NCT05564936

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.